Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024.

BMJ health & care informatics·2026
Same author

Assessing and Improving Access to Health and Social Care Services for Children Rendered Vulnerable by Abuse: Protocol for a Cross-Sectoral Longitudinal, Mixed Methods, Multi-Country Study Using Nationwide Data in Europe.

International journal of population data science·2026
Same author

Parental acceptability of newborn screening expansion in the genomic era: A nationwide French survey informed by the Theoretical Framework of Acceptability (SeDeN-p3).

PloS one·2026
Same author

Factors associated with an unfavorable outcome according to age in patients with COVID-19 admitted to intensive care in mainland France during the first three periods of the pandemic: a nationwide cohort study.

Frontiers in medicine·2026
Same author

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Annales d'endocrinologie·2026
Same author

Long-Term Cardiovascular Impact of Postpartum Treatment After Hypertensive Disorders of Pregnancy: Population-Based Cohort Study.

BJOG : an international journal of obstetrics and gynaecology·2026

Related Experiment Video

Updated: May 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Relative survival multistate Markov model.

Ella Huszti1, Michal Abrahamowicz, Ahmadou Alioum

  • 1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Statistics in Medicine
|November 5, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a new Markov relative survival (MRS) model to address competing risks and unknown causes of death in prognostic research. The MRS model provides less biased estimates for prognostic factors in cancer studies.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Related Experiment Videos

Last Updated: May 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Cancer Research

Background:

  • Prognostic studies face challenges in separating competing risks and handling uncertain causes of death.
  • Multistate Markov models analyze competing risks, while relative survival methods estimate disease-specific mortality without cause-of-death data.

Purpose of the Study:

  • To propose and evaluate a novel Markov relative survival (MRS) model combining multistate Markov and relative survival methodologies.
  • To address limitations in existing models regarding competing risks and unknown causes of death in prognostic studies.

Main Methods:

  • The proposed MRS model extends the multistate Markov piecewise constant intensities model.
  • It models the intensity of death transitions as a sum of excess hazard and expected natural mortality hazard from life tables.
  • Model evaluation was performed using simulations based on colon cancer registry data and applied to colorectal cancer data.

Main Results:

  • Simulation results demonstrated nearly unbiased estimates of prognostic factor effects using the MRS model.
  • Application to colorectal cancer data showed the MRS model significantly reduced bias compared to conventional Markov models.
  • The reduction in bias was particularly notable when prognostic factor effects on different mortality types varied substantially.

Conclusions:

  • The new Markov relative survival (MRS) model effectively integrates competing risks and relative survival analyses.
  • The MRS model offers improved accuracy in estimating prognostic factor effects, especially when causes of death are unknown or varied.
  • This methodology enhances prognostic research, particularly in registry-based cancer studies.